A detailed history of Salem Investment Counselors Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Salem Investment Counselors Inc holds 131,022 shares of ABBV stock, worth $22 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
131,022
Previous 130,775 0.19%
Holding current value
$22 Million
Previous $22.4 Million 15.35%
% of portfolio
0.8%
Previous 0.73%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$163.84 - $199.33 $40,468 - $49,234
247 Added 0.19%
131,022 $25.9 Million
Q2 2024

Jul 11, 2024

BUY
$154.79 - $180.76 $590,214 - $689,237
3,813 Added 3.0%
130,775 $22.4 Million
Q1 2024

Apr 11, 2024

BUY
$159.82 - $182.1 $119,705 - $136,392
749 Added 0.59%
126,962 $23.1 Million
Q4 2023

Jan 16, 2024

BUY
$137.6 - $154.97 $291,987 - $328,846
2,122 Added 1.71%
126,213 $19.6 Million
Q3 2023

Oct 04, 2023

BUY
$133.59 - $154.65 $67,462 - $78,098
505 Added 0.41%
124,091 $18.5 Million
Q2 2023

Jul 19, 2023

SELL
$132.51 - $164.9 $100,707 - $125,324
-760 Reduced 0.61%
123,586 $16.7 Million
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $1.08 Million - $1.25 Million
7,494 Added 6.41%
124,346 $19.8 Million
Q4 2022

Feb 15, 2023

BUY
$138.31 - $165.87 $225,168 - $270,036
1,628 Added 1.41%
116,852 $18.9 Million
Q3 2022

Nov 09, 2022

SELL
$134.21 - $153.93 $45,497 - $52,182
-339 Reduced 0.29%
115,224 $15.5 Million
Q2 2022

Aug 17, 2022

SELL
$137.62 - $174.96 $915,861 - $1.16 Million
-6,655 Reduced 5.45%
115,563 $17.7 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $2.21 Million - $2.75 Million
-16,770 Reduced 12.07%
122,218 $19.8 Million
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $688,733 - $871,447
6,411 Added 4.84%
138,988 $18.8 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $265,148 - $300,983
2,492 Added 1.92%
132,577 $14.3 Million
Q2 2021

Aug 17, 2021

BUY
$105.21 - $117.21 $1.54 Million - $1.72 Million
14,677 Added 12.72%
130,085 $14.7 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $206,032 - $226,816
2,014 Added 1.78%
115,408 $12.5 Million
Q4 2020

Feb 17, 2021

BUY
$80.49 - $108.67 $371,300 - $501,294
4,613 Added 4.24%
113,394 $12.2 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $2.25 Million - $2.64 Million
26,218 Added 31.76%
108,781 $9.53 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $24,652 - $32,988
336 Added 0.41%
82,563 $8.11 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $103,329 - $156,659
1,602 Added 1.99%
82,227 $6.27 Million
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $31,232 - $39,078
-433 Reduced 0.53%
80,625 $7.14 Million
Q3 2019

Nov 13, 2019

BUY
$62.98 - $75.72 $22,231 - $26,729
353 Added 0.44%
81,058 $6.14 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $253,667 - $324,246
3,861 Added 5.02%
80,705 $5.87 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $363,097 - $427,348
-4,707 Reduced 5.77%
76,844 $7.27 Million
Q4 2018

Feb 15, 2019

BUY
$77.85 - $96.01 $366,439 - $451,919
4,707 Added 6.13%
81,551 $7.52 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $712,435 - $792,004
-8,013 Reduced 9.44%
76,844 $7.27 Million
Q2 2018

Aug 15, 2018

SELL
$89.78 - $106.23 $471,614 - $558,026
-5,253 Reduced 5.83%
84,857 $7.86 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $145,559 - $194,918
-1,582 Reduced 1.73%
90,110 $8.31 Million
Q4 2017

Feb 16, 2018

SELL
$89.56 - $98.21 $562,257 - $616,562
-6,278 Reduced 6.41%
91,692 $8.87 Million
Q3 2017

Nov 16, 2017

BUY
$69.85 - $89.22 $6.84 Million - $8.74 Million
97,970
97,970 $8.77 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Salem Investment Counselors Inc Portfolio

Follow Salem Investment Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.